(Q43879292)

27 November 2017

title

Comparison of abdominal MRI with diffusion-weighted imaging to 68Ga-DOTATATE PET/CT in detection of neuroendocrine tumors of the pancreas (English)

1 reference

27 November 2017

0 references

5

1 reference

27 November 2017

7

1 reference

27 November 2017

9

Maximilian F Reiser

1 reference

27 November 2017

author name string

Christine Schmid-Tannwald

1

1 reference

27 November 2017

Christoph M Schmid-Tannwald

2

1 reference

27 November 2017

John N Morelli

3

1 reference

27 November 2017

Ralph Neumann

4

1 reference

27 November 2017

Nathalie Jansen

6

1 reference

27 November 2017

Nicolai Schramm

8

1 reference

27 November 2017

Carsten Rist

10

1 reference

27 November 2017

publication date

5 March 2013

1 reference

27 November 2017

number of pages

11

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

27 November 2017

volume

40

1 reference

27 November 2017

issue

6

1 reference

27 November 2017

page(s)

897-907

1 reference

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

Pancreatic Endocrine Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

Diffusion-weighted MR imaging of abdominopelvic abscesses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

Quantitative analysis of diffusion-weighted magnetic resonance imaging of the pancreas: usefulness in characterizing solid pancreatic masses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

Ga-68 DOTATOC PET, endoscopic ultrasonography, and multidetector CT in the diagnosis of duodenopancreatic neuroendocrine tumors: a single-centre retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

[Quantification of immunohistochemical expression of somatostatin receptors in neuroendocrine tumors using 68Ga-DOTATATE PET/CT].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

[PET-CT for neuroendocrine tumors and nuclear medicine therapy options].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

Role of PET/CT in the functional imaging of endocrine pancreatic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

Radiolabelling DOTA-peptides with 68Ga

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

68Ga-DOTATATE PET/CT for the early prediction of response to somatostatin receptor-mediated radionuclide therapy in patients with well-differentiated neuroendocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

Gastroenteropancreatic neuroendocrine tumors: multimodality imaging features with pathological correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

Treatment with octreotide does not reduce tumor uptake of (68)Ga-DOTATATE as measured by PET/CT in patients with neuroendocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

68Ga-DOTA-peptides versus 18F-DOPA PET for the assessment of NET patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

Role of (68)Ga-DOTATOC PET-CT in the diagnosis and staging of pancreatic neuroendocrine tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

Comparison of neuroendocrine tumor detection and characterization using DOTATOC-PET in correlation with contrast enhanced CT and delayed contrast enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

Pancreatic neuroendocrine tumor: Added value of fusion of T2-weighted imaging and high b-value diffusion-weighted imaging for tumor detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

Comparison of 68Ga-DOTATATE and 68Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00259-013-2371-5

Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis

21 January 2018

1 reference

12 December 2020

Gallium-68-DOTA-NOC PET/CT of Patients With Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Single-Center Study

1 reference

12 December 2020

Pancreatic diffusion-weighted imaging (DWI): comparison between mass-forming focal pancreatitis (FP), pancreatic cancer (PC), and normal pancreas

1 reference

12 December 2020

Diffusion‐weighted MRI: Role in detecting abdominopelvic internal fistulas and sinus tracts

1 reference

12 December 2020

Diffusion weighted MR imaging of pancreatic islet cell tumors

1 reference

12 December 2020

World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects

1 reference

12 December 2020

Successful preoperative localization of a small pancreatic insulinoma by diffusion-weighted MRI.

1 reference

12 December 2020

Functional assessment in the multimodality imaging of pancreatic neuro-endocrine tumours

1 reference

12 December 2020

10.1007/S00259-013-2371-5

Identifiers

DOI

1 reference

27 November 2017

1 reference